discontinue Verb
Alimta should only be given under the supervision of a doctor who is qualified in the use of anticancer chemotherapy .
The recommended dose of Alimta is 500 mg per square metre of body surface area ( calculated using the patient s height and weight ) .
It is given once every three weeks as an intravenous infusion lasting 10 minutes .
To reduce side effects , patients should take a corticosteroid and folic acid ( a type of vitamin ) , and receive injections of vitamin B12 during treatment with Alimta .
When Alimta is given with cisplatin , an anti-emetic medicine ( to prevent vomiting ) and fluids ( to prevent dehydration ) should also be given before or after the cisplatin dose .
Treatment should be delayed or discontinued , or the dose reduced , in patients whose blood counts are abnormal or who have certain other side effects .
Alimta is not recommended for use in patients with moderate or severe kidney problems .
For more information , see the Summary of Product Characteristics ( also part of the EPAR ) .